Where does Novaliq GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novaliq GMBH ranks #7,313 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novaliq GMBH hold?

Novaliq GMBH holds 45 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Novaliq GMBH's Innovation Score?

Novaliq GMBH has an Innovation Score of 44.9 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Novaliq GMBH focus on?

Novaliq GMBH's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 42 patents, ranking #535 of 7,163 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Novaliq GMBH's patent grant rate increasing or decreasing?

Novaliq GMBH's recent grant velocity is +73% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Novaliq GMBH's patents?

Novaliq GMBH's patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novaliq GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novaliq GMBH

USPTO PatentsView assignee record - 45 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novaliq ranks #7,313 of 49,997 tracked US assignees by granted-patent volume, with 45 patents across 12 technology areas.

#7,313
of 49,997 US assignees by volume: Top 24%
by Innovation Score (44.9/100): 17.9
avg claims per patent: +73%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7313 · Foreign Corporation #7,313 · 45 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 45 grants
UPPER-Q #7,313/49,997
PHOTO-FINISH Neo Wireless
CPC-FOCUS A61K · 12 areas
INNOV-PAR 44.9/100
CLAIMS-RICH 17.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +73% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Neo Wireless LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novaliq’s 44.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.2 pts (29%) Velocity 8.7 pts (19%) Breadth 12.2 pts (27%) Claim depth 10.7 pts (24%)

Qualcomm Incorporated · highest

85
Americorp Investments · near

45
L&L Candle · near

45
Novaliq · this assignee

45
Optiz · near

45
Vitro B de C V · near

45
3D Lighting… · lowest

7

What this shows Novaliq's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novaliq?

Each dot is one of Novaliq’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novaliq’s own 17.9 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Novaliq vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novaliq's grants concentrate

Novaliq GMBH is a focused PatentsView assignee: 12 CPC subclasses with 93.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2015. By volume, Novaliq sits between Newport Corporation and Onto Innovation Inc..

Novaliq's three-year grant acceleration

Novaliq GMBH shows 17 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Newport

45
Nippon Steel Niss…

45
Nissin ION Equipm…

45
Norco Industries

45
Neo Wireless

45
Oneplus Technolog…

45
Opower

45
Onto Innovation

45
Novaliq ◀

45

What this shows Novaliq holds 45 patents at rank #7,309, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novaliq

By rank, the assignees closest to #7,309 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Novaliq's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novaliq, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Novaliq ranks #535 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Vitro, S.A.B. de C.V. 45 L&L Candle Company, LLC 45 Optiz, Inc. 45 Americorp Investments LLC 45

Novaliq's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Novaliq GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.2%
2016	2	4.4%
2017	3	6.7%
2018	5	11.1%
2019	4	8.9%
2020	7	15.6%
2021	2	4.4%
2022	6	13.3%
2023	5	11.1%
2024	6	13.3%
2025partial year	4	8.9%

Which technologies does Novaliq GMBH patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 42

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 36

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 4

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 4

C07K - Peptides 3

C07C - Acyclic OR Carbocyclic Compounds 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C12Y - Enzymes 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Novaliq GMBH's patent record in context - here's where to go next.

Novaliq GMBH's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 93.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #7,313 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novaliq GMBH against Newport Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.